Dr. Daniel Reshef
On May 8, 2025, Two Hands Corporation’s Board of Directors appointed Dr. Daniel Reshef as a member of the Board of Directors.
Highest-materiality recent filing
Two Hands Corp. issues 535M shares to officers, directors, and consultants under equity plan
Board approved issuance of 535M shares under 2026 Equity Incentive Plan on May 18, 2026.
Two Hands issues 200M shares to former CEO to settle $1.84M debt, completing 500M share issuance
Issued 200M shares of common stock to former CEO on Dec 4, 2025, final tranche under settlement agreement.
Daniel Reshef resigned as director effective Nov 20, 2025; board now consists of Emil Assentato, Craig Marshak, and Matthew Stark.
Two Hands Corp changes control; new CEO/CFO/Board chair Assentato owns 57% after note conversion
Issued 3 billion shares to Emil Assentato upon conversion of $300,000 notes at $0.0001/share.
Two Hands receives conditional CSE approval for common shares listing
Conditional approval granted July 28, 2022 by Canadian Securities Exchange for common share listing.
Sold 80,000 shares of Series C Preferred Stock to SRAX, Inc. on June 30, 2022.
Two Hands Corporation announces 1-for-1,000 reverse stock split effective April 27, 2022
Reverse stock split of common stock at 1-for-1,000 ratio approved by stockholders on March 21, 2022.
Two Hands Corporation doubles authorized shares from 3B to 6B
Authorized shares increased from 3,001,000,000 to 6,001,000,000 effective July 16, 2021.
Two Hands sells $1M Series C Preferred to SRAX; amends certificate for 30K shares
Sold 10,000 Series C Preferred shares at $100 each to SRAX, Inc. for $1,000,000 aggregate.
On May 8, 2025, Two Hands Corporation’s Board of Directors appointed Dr. Daniel Reshef as a member of the Board of Directors.
appointed Matthew Stark as the Company’s Chief Financial Officer and a member of the Board of Directors.
accepted the resignation from Andrew Kucharchuk as the Company’s Chief Financial Officer and member of the Board of Directors.
the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors.
the Board of Directors appointed Andrew Kucharchuk as the Company's Chief Financial Officer.
the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors.
On January 3, 2025, the Company accepted the resignation from Emil Assentato as the Company's Chief Financial Officer.
On January 3, 2025, the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors effective immediately.
On January 3, 2025, the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors effective immediately.
On April 14, 2022, the Board of Directors appointed Yan Namer, age 50, as a member of the Board of Directors and Audit Committee effective immediately.
Max materiality 0.95 · Median 0.40 · Most common event other_material